Literature DB >> 23955644

Completeness of case ascertainment at the Irish National Cancer Registry.

K O'Brien1, H Comber, L Sharp.   

Abstract

BACKGROUND: Cancer registries play a major role in cancer control, including quantifying the burden of cancer in the population, informing health service planning, and evaluating service provision. Registries must achieve a high level of completeness of case ascertainment. AIM: Completeness of case ascertainment for the National Cancer Registry (NCR) in Ireland was estimated.
METHODS: For all invasive cancers, and the four most common sites, we used two quantitative methods which use information from death certificates to obtain estimates of completeness of registration-the Lincoln-Petersen (LP) estimator (which provides a lower bound estimate) and the flow method (which estimates completeness at a fixed time-point, in this case 5 years). Data were extracted at the end of 2010. Independent case ascertainment was used to assess completeness of breast cancer registration in the 50-64 age group and of rectal cancer in surgical patients diagnosed in 2007.
RESULTS: Completeness of case ascertainment was >99 % for the breast screening age-group and for surgical rectal cancer cases. A lower bound on completeness of case ascertainment for all invasive cancers excluding non-melanoma skin cancers is 94.3 % using the LP estimator. The estimate from the flow method is 97 % after 5 years, [95 % confidence interval (96.2 %, 97.7 %)]. Five-year levels of completeness for the four commonest cancers using the flow method were: colorectal, 97.4 %; lung, 98.7 %; prostate, 95.8 % and breast, 98.0 %.
CONCLUSION: The estimated levels of completeness for the NCR are satisfactory. Further work is required to compare the methods used.

Entities:  

Mesh:

Year:  2013        PMID: 23955644     DOI: 10.1007/s11845-013-0993-z

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  16 in total

1.  Population-based cancer registries: the invisible key to cancer control.

Authors:  David H Brewster; Jan-Willem Coebergh; Hans H Storm
Journal:  Lancet Oncol       Date:  2005-04       Impact factor: 41.316

2.  Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness.

Authors:  Inger Kristin Larsen; Milada Småstuen; Tom Børge Johannesen; Frøydis Langmark; Donald Maxwell Parkin; Freddie Bray; Bjørn Møller
Journal:  Eur J Cancer       Date:  2008-12-16       Impact factor: 9.162

3.  Completeness of case ascertainment in a Scottish regional cancer registry for the year 1992.

Authors:  D H Brewster; J Crichton; J C Harvey; G Dawson
Journal:  Public Health       Date:  1997-09       Impact factor: 2.427

4.  Data quality at the Icelandic Cancer Registry: comparability, validity, timeliness and completeness.

Authors:  Lara Gudrun Sigurdardottir; Jon Gunnlaugur Jonasson; Sigrun Stefansdottir; Anna Jonsdottir; Gudridur Helga Olafsdottir; Elinborg Jona Olafsdottir; Laufey Tryggvadottir
Journal:  Acta Oncol       Date:  2012-09       Impact factor: 4.089

5.  EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary.

Authors:  Milena Sant; Claudia Allemani; Mariano Santaquilani; Arnold Knijn; Francesca Marchesi; Riccardo Capocaccia
Journal:  Eur J Cancer       Date:  2009-01-24       Impact factor: 9.162

6.  Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012.

Authors:  J Ferlay; E Steliarova-Foucher; J Lortet-Tieulent; S Rosso; J W W Coebergh; H Comber; D Forman; F Bray
Journal:  Eur J Cancer       Date:  2013-02-26       Impact factor: 9.162

7.  How do cancer registries in europe estimate completeness of registration?

Authors:  Irene Schmidtmann; Maria Blettner
Journal:  Methods Inf Med       Date:  2009-03-31       Impact factor: 2.176

Review 8.  Evaluation of data quality in the cancer registry: principles and methods Part II. Completeness.

Authors:  D Max Parkin; Freddie Bray
Journal:  Eur J Cancer       Date:  2009-01-06       Impact factor: 9.162

9.  Completeness of case ascertainment and survival time error in English cancer registries: impact on 1-year survival estimates.

Authors:  H Møller; S Richards; N Hanchett; S P Riaz; M Lüchtenborg; L Holmberg; D Robinson
Journal:  Br J Cancer       Date:  2011-05-10       Impact factor: 7.640

10.  Completeness of cancer registration: a new method for routine use.

Authors:  J Bullard; M P Coleman; D Robinson; J M Lutz; J Bell; J Peto
Journal:  Br J Cancer       Date:  2000-03       Impact factor: 7.640

View more
  12 in total

1.  Variation in treatment and outcome in the early stage oral cavity squamous cell carcinoma.

Authors:  Darragh S Gogarty; Paul Lennon; Sandra Deady; J Barry O'Sullivan; Orla McArdle; Mary Leader; Patrick Sheahan; James Paul O'Neill
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-08-23       Impact factor: 2.503

2.  Pre-diagnosis employment status and financial circumstances predict cancer-related financial stress and strain among breast and prostate cancer survivors.

Authors:  Linda Sharp; Aileen Timmons
Journal:  Support Care Cancer       Date:  2015-07-05       Impact factor: 3.603

3.  Epidemiology of chronic hepatitis B virus in Ireland using routinely collected surveillance and administrative data, 2004-2014.

Authors:  Caroline E van Gemert; Niamh Murphy; Tara A Mitchell; Margaret E Hellard; Lelia Thornton
Journal:  Ir J Med Sci       Date:  2017-12-09       Impact factor: 1.568

4.  Aggressive medullary thyroid cancer, an analysis of the Irish National Cancer Registry.

Authors:  P Lennon; S Deady; N White; D Lambert; M L Healy; A Green; J Kinsella; C Timon; J P O' Neill
Journal:  Ir J Med Sci       Date:  2016-04-15       Impact factor: 1.568

5.  National Incidence, Management and Survival of Urachal Carcinoma.

Authors:  Dearbhaile C Collins; Kyra Velázquez-Kennedy; Sandra Deady; Adrian P Brady; Paul Sweeney; Derek G Power
Journal:  Rare Tumors       Date:  2016-10-05

6.  Effect of investigation intensity and treatment differences on prostate cancer survivor's physical symptoms, psychological well-being and health-related quality of life: a two country cross-sectional study.

Authors:  Anna T Gavin; David Donnelly; Conan Donnelly; Frances J Drummond; Eileen Morgan; Gerard J Gormley; Linda Sharp
Journal:  BMJ Open       Date:  2016-12-19       Impact factor: 2.692

7.  Affluence and Private Health Insurance Influence Treatment and Survival in Non-Hodgkin's Lymphoma.

Authors:  Harry Comber; Marianna De Camargo Cancela; Trutz Haase; Howard Johnson; Linda Sharp; Jonathan Pratschke
Journal:  PLoS One       Date:  2016-12-19       Impact factor: 3.240

8.  Mortality reductions due to mammography screening: Contemporary population-based data.

Authors:  James A Hanley; Ailish Hannigan; Katie M O'Brien
Journal:  PLoS One       Date:  2017-12-20       Impact factor: 3.240

9.  The magnitude and characteristics of the population of cancer survivors: using population-based estimates of cancer prevalence to inform service planning for survivorship care.

Authors:  Linda Sharp; Sandra Deady; Pamela Gallagher; Michal Molcho; Alison Pearce; Audrey Alforque Thomas; Aileen Timmons; Harry Comber
Journal:  BMC Cancer       Date:  2014-10-15       Impact factor: 4.430

10.  Indicators for early assessment of palliative care in lung cancer patients: a population study using linked health data.

Authors:  Maria Kelly; Katie M O'Brien; Michael Lucey; Kerri Clough-Gorr; Ailish Hannigan
Journal:  BMC Palliat Care       Date:  2018-02-26       Impact factor: 3.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.